Hey, explain me about the concept of fibrinolysis, you know. It is the final step where the clot is dissolved when the vessel got healed, right? So, this concept, explain me and what all are the testables through this concept in the USMLE Step 1. I want a topper-like notes, like useful for step 1.
Your correction is partially right — fibrinolysis is activated during clot formation (not only after healing), to limit clot growth from the start, and then continues to dissolve the clot as the wound heals.

| Component | Role |
|---|---|
| Plasminogen | Inactive zymogen (precursor), circulates in blood |
| tPA (tissue plasminogen activator) | Primary physiologic activator; released by endothelial cells |
| uPA (urokinase-type PA) | Second activator; mainly drives extravascular fibrinolysis (inflammatory contexts) |
| Plasmin | Active serine protease; digests fibrin |
⚠️ This specificity is lost at pharmacologic doses of tPA (alteplase) — too much plasmin overwhelms the inhibitory controls → systemic lytic state → bleeding risk
| Substrate | Product | Clinical Significance |
|---|---|---|
| Cross-linked fibrin (clot) | D-dimer + fibrin degradation products (FDPs) | D-dimer is diagnostic for DVT/PE, DIC |
| Fibrinogen (in systemic lysis) | Fibrinogen degradation products (FDPs) | Seen in DIC, thrombolytic overdose |
| Coagulation factors (at high doses) | Degraded V, VIII | Bleeding risk with thrombolytics |
| Inhibitor | What It Inhibits | Notes |
|---|---|---|
| PAI-1 (plasminogen activator inhibitor-1) | tPA and uPA | Major inhibitor of plasminogen activators; synthesized by endothelial cells; rapidly clears tPA from blood |
| PAI-2 | tPA and uPA (lesser extent) | Prominent in pregnancy |
| α₂-antiplasmin (α₂-plasmin inhibitor) | Plasmin | Major inhibitor of free plasmin; binds kringle domain 1 then blocks active site; overwhelmed by therapeutic tPA doses |
| TAFI (Thrombin-Activatable Fibrinolysis Inhibitor) | Removes C-terminal lysines from fibrin | Limits plasminogen/tPA binding; thrombin + thrombomodulin activates it |
| Factor XIIIa | Indirectly (cross-links α₂-antiplasmin to fibrin) | Prevents premature clot lysis |
| Drug | Mechanism | Fibrin-Specific? | Notes |
|---|---|---|---|
| Alteplase (tPA, rt-PA) | Recombinant tPA → activates plasminogen | Yes (at physiologic doses) | Drug of choice for ischemic stroke (within 4.5 hrs), STEMI if no PCI available |
| Reteplase (rPA) | Recombinant tPA variant | Yes | Double bolus IV; used in STEMI |
| Tenecteplase (TNK-tPA) | Engineered tPA variant | Yes | Single weight-based bolus; longer half-life; used in STEMI |
| Streptokinase | Bacterial protein; binds plasminogen → forms an activator complex | No (non-fibrin-specific) | Systemic lytic state; antigenic (↑ antibodies, allergic reactions); cannot re-use |
| Urokinase (uPA) | Directly converts plasminogen → plasmin | No | Used for catheter-directed thrombolysis |
| Anistreplase | Streptokinase + plasminogen complex | No | Older agent |
| Drug | Mechanism | Use |
|---|---|---|
| Aminocaproic acid (ε-aminocaproic acid) | Lysine analogue → blocks kringle domains → prevents plasminogen/tPA binding to fibrin | Hemostasis after surgery, hemophilia bleeds, post-tonsillectomy bleeding |
| Tranexamic acid (TXA) | Same mechanism as aminocaproic acid (lysine analogue) | Trauma, surgical bleeding, heavy menstrual bleeding |
Mnemonic: Aminocaproic acid = Anti-fibrinolytic — it occupies the lysine-binding sites so plasminogen cannot attach to fibrin.
| Concept | Testable Fact |
|---|---|
| Plasminogen activator | tPA (physiologic); released by endothelial cells |
| Kringle domains | Bind lysine on fibrin → clot specificity → protected from α₂-antiplasmin |
| Major inhibitor of plasmin | α₂-antiplasmin |
| Major inhibitor of tPA | PAI-1 |
| D-dimer | Product of cross-linked fibrin degradation; rules out DVT/PE |
| FDPs without D-dimer | From fibrinogen degradation only (not cross-linked fibrin) |
| DIC labs | ↑ PT, ↑ aPTT, ↑ D-dimer, ↓ fibrinogen, ↓ platelets, schistocytes on smear |
| Streptokinase | Antigenic, non-fibrin-specific, cannot re-administer |
| Aminocaproic acid / TXA | Lysine analogues → antifibrinolytic |
| Alteplase contraindications | Hemorrhagic stroke ever; ischemic stroke <3 months; aortic dissection |
| Fibrin specificity at high tPA doses | LOST → systemic lytic state → bleeding |
| Positive feedback in lysis | Partial fibrin degradation exposes more lysine residues → more plasmin binding |
| TAFI | Thrombin-activatable fibrinolysis inhibitor; removes lysines → slows lysis |
| Factor XIIIa role | Cross-links fibrin AND cross-links α₂-antiplasmin to fibrin → protects clot from early lysis |
VESSEL INJURY
↓
Coagulation cascade → Thrombin → Fibrin clot (Factor XIIIa cross-links it)
↓ (simultaneously)
Endothelial cells release tPA
↓
tPA + Plasminogen bind to FIBRIN (via kringle-lysine interaction)
→ Ternary complex → Plasmin (locally generated, fibrin-specific)
↓
Plasmin degrades cross-linked fibrin → D-DIMER + FDPs
↓
Clot dissolves; vessel patent again
INHIBITORS:
PAI-1 → blocks tPA/uPA
α₂-antiplasmin → blocks free plasmin
TAFI → removes lysines from fibrin (limits plasmin binding)
Aminocaproic acid / TXA → occupy lysine binding sites (drugs)
Step 1 topper like hy and short including everything
Plasminogen ──[tPA / uPA]──► PLASMIN ──► Fibrin ──► D-dimer + FDPs
▲
(on clot surface only)
| Player | What It Is | One-liner |
|---|---|---|
| Plasminogen | Inactive zymogen | Circulates in blood; activated ON the fibrin clot |
| tPA | Tissue plasminogen activator | Made by endothelium; main physiologic activator |
| uPA (urokinase) | Urokinase-type PA | Extravascular fibrinolysis; inflammatory states |
| Plasmin | Active serine protease | The actual "clot dissolver" |
| PAI-1 | Plasminogen activator inhibitor-1 | Blocks tPA/uPA → made by endothelium |
| α₂-antiplasmin | Plasmin inhibitor | Destroys free plasmin; can't reach clot-bound plasmin |
| TAFI | Thrombin-activatable fibrinolysis inhibitor | Removes lysines from fibrin → slows lysis |
High-dose tPA (pharmacologic) → overwhelms PAI-1 and α₂-antiplasmin → clot specificity LOST → systemic lysis → BLEEDING
| Product | Source | Significance |
|---|---|---|
| D-dimer | Plasmin on cross-linked fibrin (Factor XIIIa-stabilized) | Diagnoses active clot formation + lysis (DVT/PE, DIC) |
| FDPs (fibrin/fibrinogen degradation products) | Plasmin on fibrin OR fibrinogen | Less specific; elevated in DIC, liver disease |
D-dimer requires cross-linked fibrin → needs Factor XIIIa to have acted first → not elevated from fibrinogen breakdown alone
| Drug | Mechanism | Fibrin-Specific? | Key Facts |
|---|---|---|---|
| Alteplase (tPA) | Recombinant tPA | ✅ Yes | Stroke (≤4.5 hrs), STEMI, massive PE |
| Reteplase | tPA variant | ✅ Yes | Double IV bolus; STEMI |
| Tenecteplase (TNK) | Engineered tPA | ✅ Yes | Single weight-based bolus; STEMI |
| Streptokinase | Bacterial → forms plasminogen-activator complex | ❌ No | Antigenic → allergic rxn; can't re-use (antibodies); systemic lysis |
| Urokinase | Directly converts plasminogen → plasmin | ❌ No | Catheter-directed thrombolysis |
| Drug | Mechanism | Uses |
|---|---|---|
| Aminocaproic acid | Lysine analogue → blocks kringle domains → no plasminogen binding to fibrin | Post-op bleeding, hemophilia, tonsillectomy |
| Tranexamic acid (TXA) | Same mechanism | Trauma, surgery, heavy periods |
Both are competitive inhibitors of plasminogen/plasmin binding to fibrin — they occupy the lysine-binding sites
| Lab | Value | Why |
|---|---|---|
| PT / aPTT | ↑ | Clotting factors consumed |
| Fibrinogen | ↓ | Consumed + degraded by plasmin |
| Platelets | ↓ | Consumed in microthrombi |
| D-dimer | ↑↑ | Massive clot lysis |
| FDPs | ↑↑ | Fibrin/fibrinogen degradation |
| Smear | Schistocytes | RBCs sheared by fibrin strands |
| Situation | D-dimer |
|---|---|
| Suspected DVT/PE (low pre-test probability) | If negative → rules OUT (high sensitivity) |
| DIC | ↑↑ (with ↓ fibrinogen, ↓ platelets) |
| Post-surgery / pregnancy / cancer | False positive (↑ but not diagnostic) |
| Fibrinogenolysis only (no cross-linked fibrin) | Normal D-dimer, elevated FDPs only |
tPA (from endothelium) converts plasminogen → plasmin on fibrin surface (via kringle-lysine binding); plasmin digests cross-linked fibrin → D-dimer; free plasmin is killed by α₂-antiplasmin; tPA is killed by PAI-1; drugs mimicking tPA = thrombolytics; drugs blocking lysine binding = antifibrinolytics.
Can you make a time table daily to solve questions of complete u world starting from today till june 30
| Stat | Value |
|---|---|
| Total questions | 3,658 |
| Total days (May 19 – Jun 30) | 43 days |
| Sundays off (May 25, Jun 1, 8, 15, 22, 29) | 6 days |
| Active study days | 37 days |
| Questions/day needed | 3658 ÷ 37 = ~99 Qs/day |
| Target: 100 Qs/day | Finishes entire bank with buffer |
| Time | Activity | Duration |
|---|---|---|
| 8:00–8:30 AM | Morning review — yesterday's marked/incorrect | 30 min |
| 8:30–10:30 AM | Block 1 — 40 Qs (Timed) | 2 hrs |
| 10:30–11:30 AM | Review Block 1 explanations deeply | 1 hr |
| 11:30–1:30 PM | Block 2 — 40 Qs (Timed) | 2 hrs |
| 1:30–2:30 PM | Lunch break | 1 hr |
| 2:30–3:30 PM | Review Block 2 explanations | 1 hr |
| 3:30–4:30 PM | Block 3 — 20 Qs (Tutor mode) | 1 hr |
| 4:30–5:15 PM | Review Block 3 + make notes | 45 min |
| 5:15–6:00 PM | Rapid-fire revision — FA/Sketchy/Anki on today's topics | 45 min |
80 Qs timed + 20 Qs tutor = 100 Qs/day with full review each day
| Week | Dates | Subjects | Total Qs |
|---|---|---|---|
| Week 1 | May 19–24 | Pathology (819 Qs) — Part 1 | ~600 |
| Week 2 | May 26–31 | Pathology finish (219) + Pharmacology start (331) | ~550 |
| Week 3 | Jun 2–7 | Pharmacology finish (219) + Pathophysiology start (231) | ~450 |
| Week 4 | Jun 9–14 | Pathophysiology finish (257) + Anatomy (308) | ~565 |
| Week 5 | Jun 16–21 | Microbiology (348) + Behavioral Science start (154) | ~500 |
| Week 6 | Jun 23–28 | Behavioral Sci finish (100) + Physiology (268) + Biochemistry (159) | ~527 |
| Final push | Jun 29–30 | Immunology (132) + Biostatistics (121) + Genetics (107) + Embryology (75) + Histology (29) | ~464 |
| Day | Date | Focus | Qs |
|---|---|---|---|
| Mon | May 19 | Pathology — Cell injury, Inflammation, Neoplasia | 100 |
| Tue | May 20 | Pathology — Cardiovascular | 100 |
| Wed | May 21 | Pathology — Pulmonary | 100 |
| Thu | May 22 | Pathology — GI + Hepatobiliary | 100 |
| Fri | May 23 | Pathology — Renal + Endocrine | 100 |
| Sat | May 24 | Pathology — Heme/Onc + MSK | 100 |
| Sun | May 25 | OFF | — |
| Day | Date | Focus | Qs |
|---|---|---|---|
| Mon | May 26 | Pathology — Neuro + Repro (finish) | 100 |
| Tue | May 27 | Pathology — Remaining + Review weak areas | 119 |
| Wed | May 28 | Pharmacology — Autonomic + CNS drugs | 100 |
| Thu | May 29 | Pharmacology — Cardiovascular drugs | 100 |
| Fri | May 30 | Pharmacology — Antimicrobials | 100 |
| Sat | May 31 | Pharmacology — Endocrine + Chemo drugs | 100 |
| Sun | Jun 1 | OFF | — |
| Day | Date | Focus | Qs |
|---|---|---|---|
| Mon | Jun 2 | Pharmacology — Remaining (finish) | ~150 |
| Tue | Jun 3 | Pathophysiology — Cardio | 100 |
| Wed | Jun 4 | Pathophysiology — Pulm + Renal | 100 |
| Thu | Jun 5 | Pathophysiology — GI + Endocrine | 100 |
| Fri | Jun 6 | Pathophysiology — Neuro + Heme | 100 |
| Sat | Jun 7 | Pathophysiology — Remaining (finish) | ~88 |
| Sun | Jun 8 | OFF | — |
| Day | Date | Focus | Qs |
|---|---|---|---|
| Mon | Jun 9 | Anatomy — Head & Neck | 100 |
| Tue | Jun 10 | Anatomy — Upper limb + Lower limb | 100 |
| Wed | Jun 11 | Anatomy — Thorax + Abdomen | 100 |
| Thu | Jun 12 | Anatomy — finish (8 Qs leftover) + Microbiology — Bacteria | 100 |
| Fri | Jun 13 | Microbiology — Viruses | 100 |
| Sat | Jun 14 | Microbiology — Fungi + Parasites | 100 |
| Sun | Jun 15 | OFF | — |
| Day | Date | Focus | Qs |
|---|---|---|---|
| Mon | Jun 16 | Microbiology — Remaining + Behavioral Sci start | 100 |
| Tue | Jun 17 | Behavioral Science — Epidemiology + Ethics | 100 |
| Wed | Jun 18 | Behavioral Science — finish + Physiology start | 100 |
| Thu | Jun 19 | Physiology — Cardio + Pulm | 100 |
| Fri | Jun 20 | Physiology — Renal + GI | 100 |
| Sat | Jun 21 | Physiology — Neuro + Endocrine (finish) | 68 |
| Sun | Jun 22 | OFF | — |
| Day | Date | Focus | Qs |
|---|---|---|---|
| Mon | Jun 23 | Biochemistry — Metabolism + Molecular bio | 100 |
| Tue | Jun 24 | Biochemistry — finish (59) + Immunology start | 100 |
| Wed | Jun 25 | Immunology — finish (32 leftover) + Biostatistics | 100 |
| Thu | Jun 26 | Biostatistics — finish (21) + Genetics | 100 |
| Fri | Jun 27 | Genetics — finish (7) + Embryology | 100 |
| Sat | Jun 28 | Embryology — finish + Histology (29) + Spillover/Review | ~54 |
| Sun | Jun 29 | OFF | — |
| Day | Date | Activity |
|---|---|---|
| Mon | Jun 30 | Full comprehensive review — All marked questions + weak subjects. Do a mixed 40Q timed block to simulate real test feel. |
| End of Week | Qs Completed | % Done |
|---|---|---|
| May 24 | ~600 | 16% |
| May 31 | ~1,219 | 33% |
| Jun 7 | ~1,757 | 48% |
| Jun 14 | ~2,357 | 64% |
| Jun 21 | ~2,957 | 81% |
| Jun 28 | ~3,511 | 96% |
| Jun 30 | 3,658 | 100% ✅ |
Bottom line: 100 Qs/day, 6 days/week, 37 active days = entire UWorld done with 1 full review day left. Stick to the 80 timed + 20 tutor split so you build speed AND understand concepts simultaneously.
Wait today is april 13 2026 make from tomorrow
| Stat | Value |
|---|---|
| Total questions | 3,658 |
| Total days (Apr 14 – Jun 30) | 78 days |
| Sundays off (Apr 19, 26, May 3, 10, 17, 24, 31, Jun 7, 14, 21, 28) | 11 days |
| Active study days | 67 days |
| Questions/day needed | 3658 ÷ 67 = ~55 Qs/day |
| Target: 60 Qs/day | Finishes bank with ~5 days buffer for revision |
Great news — you have a very comfortable timeline. 60 Qs/day is very doable in 8–9 hrs, leaving significant time for deep review, notes, and Anki/FA alongside each subject.
| Time | Activity | Duration |
|---|---|---|
| 8:00–8:30 AM | Morning review — previous day's marked/incorrect Qs | 30 min |
| 8:30–10:00 AM | Block 1 — 40 Qs (Timed mode) | 1.5 hrs |
| 10:00–11:15 AM | Deep review of Block 1 explanations + notes | 1 hr 15 min |
| 11:15–11:30 AM | Short break | 15 min |
| 11:30–12:30 PM | Block 2 — 20 Qs (Tutor mode) | 1 hr |
| 12:30–1:30 PM | Lunch break | 1 hr |
| 1:30–2:30 PM | Review Block 2 + update wrong answer log | 1 hr |
| 2:30–4:30 PM | First Aid / Sketchy / Pathoma — parallel reading of today's subject | 2 hrs |
| 4:30–5:30 PM | Anki / Flashcard review (new + due cards) | 1 hr |
| 5:30–6:00 PM | Plan tomorrow, review weak points | 30 min |
40 timed + 20 tutor = 60 Qs/day with full deep review + resource reading every day
| Subject | Qs | Days Needed @ 60/day |
|---|---|---|
| Pathology | 819 | ~14 days |
| Pharmacology | 550 | ~9 days |
| Pathophysiology | 488 | ~8 days |
| Anatomy | 308 | ~5 days |
| Microbiology | 348 | ~6 days |
| Behavioral Science | 254 | ~4 days |
| Physiology | 268 | ~4 days |
| Biochemistry | 159 | ~3 days |
| Immunology | 132 | ~2 days |
| Biostatistics | 121 | ~2 days |
| Genetics | 107 | ~2 days |
| Embryology | 75 | ~1 day |
| Histology | 29 | ~1 day |
| TOTAL | 3,658 | ~61 days → done by ~Jun 18 |
Leaves Jun 19–30 (12 days) purely for revision of wrong/marked questions
| Day | Date | Subject Focus | Qs |
|---|---|---|---|
| Mon | Apr 14 | Pathology — Cell injury, Apoptosis, Necrosis | 60 |
| Tue | Apr 15 | Pathology — Inflammation (acute + chronic) | 60 |
| Wed | Apr 16 | Pathology — Tissue repair, Wound healing | 60 |
| Thu | Apr 17 | Pathology — Neoplasia (basics, carcinogenesis) | 60 |
| Fri | Apr 18 | Pathology — Hematologic neoplasms (leukemia/lymphoma) | 60 |
| Sat | Apr 19 | Pathology — Vascular pathology | 60 |
| Sun | Apr 19 | OFF ☀️ | — |
| Day | Date | Subject Focus | Qs |
|---|---|---|---|
| Mon | Apr 21 | Pathology — Cardiovascular | 60 |
| Tue | Apr 22 | Pathology — Pulmonary | 60 |
| Wed | Apr 23 | Pathology — GI (esophagus → small bowel) | 60 |
| Thu | Apr 24 | Pathology — GI (colon, liver, pancreas) | 60 |
| Fri | Apr 25 | Pathology — Renal | 60 |
| Sat | Apr 26 | Pathology — Endocrine | 60 |
| Sun | Apr 26 | OFF ☀️ | — |
| Day | Date | Subject Focus | Qs |
|---|---|---|---|
| Mon | Apr 28 | Pathology — MSK + Derm | 60 |
| Tue | Apr 29 | Pathology — Neuro + Repro (finish Pathology ✅) | 60 |
| Wed | Apr 30 | Pharmacology — Autonomic nervous system | 60 |
| Thu | May 1 | Pharmacology — CNS drugs (antidepressants, antipsychotics) | 60 |
| Fri | May 2 | Pharmacology — CNS drugs (antiepileptics, anesthesia, opioids) | 60 |
| Sat | May 3 | Pharmacology — Cardiovascular drugs (antihypertensives, antiarrhythmics) | 60 |
| Sun | May 3 | OFF ☀️ | — |
| Day | Date | Subject Focus | Qs |
|---|---|---|---|
| Mon | May 5 | Pharmacology — Cardiovascular (statins, anticoagulants, antiplatelets) | 60 |
| Tue | May 6 | Pharmacology — Antimicrobials Part 1 (cell wall, protein synthesis) | 60 |
| Wed | May 7 | Pharmacology — Antimicrobials Part 2 (quinolones, antifungals, antivirals) | 60 |
| Thu | May 8 | Pharmacology — Endocrine drugs (insulin, thyroid, steroids) | 60 |
| Fri | May 9 | Pharmacology — Chemotherapy + Immunosuppressants (finish Pharmacology ✅) | 60 |
| Sat | May 10 | Pathophysiology — Cardiovascular | 60 |
| Sun | May 10 | OFF ☀️ | — |
| Day | Date | Subject Focus | Qs |
|---|---|---|---|
| Mon | May 12 | Pathophysiology — Pulmonary | 60 |
| Tue | May 13 | Pathophysiology — Renal (AKI, CKD, acid-base) | 60 |
| Wed | May 14 | Pathophysiology — GI + Hepatobiliary | 60 |
| Thu | May 15 | Pathophysiology — Endocrine | 60 |
| Fri | May 16 | Pathophysiology — Hematology (anemias, coagulation) | 60 |
| Sat | May 17 | Pathophysiology — Neuro + Repro (finish Pathophysiology ✅) | 60 |
| Sun | May 17 | OFF ☀️ | — |
| Day | Date | Subject Focus | Qs |
|---|---|---|---|
| Mon | May 19 | Microbiology — Bacteriology Part 1 (Gram +ve) | 60 |
| Tue | May 20 | Microbiology — Bacteriology Part 2 (Gram –ve, atypicals) | 60 |
| Wed | May 21 | Microbiology — Virology (DNA viruses, RNA viruses) | 60 |
| Thu | May 22 | Microbiology — Mycology + Parasitology | 60 |
| Fri | May 23 | Microbiology — Remaining (finish Microbiology ✅) | 60 |
| Sat | May 24 | Anatomy — Head & Neck | 60 |
| Sun | May 24 | OFF ☀️ | — |
| Day | Date | Subject Focus | Qs |
|---|---|---|---|
| Mon | May 26 | Anatomy — Upper limb + Lower limb | 60 |
| Tue | May 27 | Anatomy — Thorax + Abdomen | 60 |
| Wed | May 28 | Anatomy — Neuroanatomy (finish Anatomy ✅) | 60 |
| Thu | May 29 | Behavioral Science — Biostatistics/Epidemiology within BS | 60 |
| Fri | May 30 | Behavioral Science — Ethics, Development, Psychiatry | 60 |
| Sat | May 31 | Behavioral Science — finish (finish Behavioral Science ✅) | 60 |
| Sun | May 31 | OFF ☀️ | — |
| Day | Date | Subject Focus | Qs |
|---|---|---|---|
| Mon | Jun 2 | Physiology — Cardiovascular + Pulmonary | 60 |
| Tue | Jun 3 | Physiology — Renal + GI | 60 |
| Wed | Jun 4 | Physiology — Neuro + Endocrine (finish Physiology ✅) | 60 |
| Thu | Jun 5 | Biochemistry — Metabolism (glycolysis, TCA, FA) | 60 |
| Fri | Jun 6 | Biochemistry — Molecular biology + Nutrition (finish Biochemistry ✅) | 60 |
| Sat | Jun 7 | Immunology — Innate + Adaptive immunity | 60 |
| Sun | Jun 7 | OFF ☀️ | — |
| Day | Date | Subject Focus | Qs |
|---|---|---|---|
| Mon | Jun 9 | Immunology — finish (finish Immunology ✅) | 72 |
| Tue | Jun 10 | Biostatistics — Full (finish Biostatistics ✅) | 60 |
| Wed | Jun 11 | Genetics — Full (finish Genetics ✅) | 60 |
| Thu | Jun 12 | Embryology + Histology — Full (finish both ✅) | 60 |
| Fri | Jun 13 | 🎉 QBANK COMPLETE — Mixed weak subject review block | 60 |
| Sat | Jun 14 | Revision Day 1 — All Incorrect Qs (252 total) Part 1 | 60 |
| Sun | Jun 14 | OFF ☀️ | — |
| Day | Date | Activity | Qs |
|---|---|---|---|
| Mon | Jun 16 | Revision — Incorrect Qs Part 2 | 60 |
| Tue | Jun 17 | Revision — All Marked Qs (65 total) + Omitted Part 1 | 60 |
| Wed | Jun 18 | Revision — Omitted Qs Part 2 (259 total) | 60 |
| Thu | Jun 19 | Revision — Omitted Qs finish + Mixed timed block (simulate exam) | 60 |
| Fri | Jun 20 | Mixed timed block — Pathology + Pharmacology (highest yield) | 60 |
| Sat | Jun 21 | Mixed timed block — Micro + Physio + Biochem | 60 |
| Sun | Jun 21 | OFF ☀️ | — |
| Day | Date | Activity |
|---|---|---|
| Mon | Jun 23 | Weak subject deep dive (whatever scored lowest) |
| Tue | Jun 24 | Mixed 60Q timed block — all subjects random |
| Wed | Jun 25 | Behavioral Science + Biostatistics revision (pure memorization) |
| Thu | Jun 26 | Pharmacology rapid review — mechanisms + side effects only |
| Fri | Jun 27 | Pathology rapid review — classic findings + buzzwords |
| Sat | Jun 28 | Full 40Q timed mock block — exam simulation |
| Sun | Jun 28 | OFF ☀️ |
| Mon | Jun 29 | Final review — only your flagged/wrong answer notebook |
| Tue | Jun 30 | Light day — No new Qs. Only read notes. Rest. Sleep early. |
| Checkpoint | Date | Qs Done | % Complete |
|---|---|---|---|
| End Week 1 | Apr 19 | ~360 | 10% |
| End Week 2 | Apr 26 | ~720 | 20% |
| End Week 4 | May 10 | ~1,440 | 39% |
| End Week 6 | May 24 | ~2,160 | 59% |
| End Week 8 | Jun 7 | ~2,880 | 79% |
| Qbank complete | Jun 13 | ~3,658 | 100% ✅ |
| Jun 30 | Jun 30 | Revision done | Ready 🎯 |
Can you make a pdf please
/home/user/uworld_timetable.htmlI cant open